Regardless of the mechanism(s) of disease pathogenesis, both systemic ALCL and BIA-ALCL share common oncogenic events; Jak1/STAT3 mutations are observed in systemic ALCL, ALK− and BIA-ALCL [54,55]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.